A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma

Overview of attention for article published in Blood, November 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

patent: 27 patents

Readers on

mendeley: 83 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 27 patents that reference this research output.

Salts of a Pim kinase inhibitor

Grant US-12043614-B2

United States of America

23 Jul 2024

Salts of a Pim kinase inhibitor

Grant US-11505540-B2

United States of America

22 Nov 2022

Formulations comprising heterocyclic protein kinase inhibitors

Grant US-11471456-B2

United States of America

18 Oct 2022

Low dose combination therapy for treatment of myeloproliferative neoplasms

Grant US-11278541-B2

United States of America

22 Mar 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 23 additional patents.